Aclarion Stock Performance
| ACON Stock | USD 7.45 0.24 3.12% |
The firm shows a Beta (market volatility) of 1.38, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aclarion will likely underperform. At this point, Aclarion has a negative expected return of -0.19%. Please make sure to confirm Aclarion's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Aclarion performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Aclarion has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Last Split Factor 1:27 | Last Split Date 2025-03-28 |
1 | Aclarion, Inc. Short Interest Down 95.6 percent in March | 04/16/2025 |
2 | Aclarion Inc Files For Mixed Shelf Of Up To 150 Mln - SEC Filing - marketscreener.com | 04/25/2025 |
3 | Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON Stock News | 05/12/2025 |
4 | Aclarion Raised to Hold at Wall Street Zen | 06/02/2025 |
5 | Aclarion Showcases NOCISCAN at Spine Surgery Conference ACON Stock News | 06/24/2025 |
6 | Aclarion Begins Patient Enrollment in Clarity Trial for Nociscan ACON Stock News | 06/25/2025 |
| Begin Period Cash Flow | 1 M |
Aclarion Relative Risk vs. Return Landscape
If you would invest 897.00 in Aclarion on April 7, 2025 and sell it today you would lose (152.00) from holding Aclarion or give up 16.95% of portfolio value over 90 days. Aclarion is currently does not generate positive expected returns and assumes 4.8166% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Aclarion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aclarion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aclarion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aclarion, and traders can use it to determine the average amount a Aclarion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0389
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACON |
Estimated Market Risk
| 4.82 actual daily | 43 57% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aclarion is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aclarion by adding Aclarion to a well-diversified portfolio.
Aclarion Fundamentals Growth
Aclarion Stock prices reflect investors' perceptions of the future prospects and financial health of Aclarion, and Aclarion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aclarion Stock performance.
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.35 | ||||
| Operating Margin | (78.56) % | ||||
| Current Valuation | 3.94 M | ||||
| Shares Outstanding | 582.37 K | ||||
| Price To Book | 0.27 X | ||||
| Price To Sales | 79.46 X | ||||
| Revenue | 45.72 K | ||||
| Gross Profit | (34.06 K) | ||||
| EBITDA | (6.26 M) | ||||
| Net Income | (6.99 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.15 M | ||||
| Book Value Per Share | 27.10 X | ||||
| Cash Flow From Operations | (5.27 M) | ||||
| Earnings Per Share | (11.50) X | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (51.26 M) | ||||
About Aclarion Performance
By examining Aclarion's fundamental ratios, stakeholders can obtain critical insights into Aclarion's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aclarion is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.Things to note about Aclarion performance evaluation
Checking the ongoing alerts about Aclarion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aclarion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aclarion generated a negative expected return over the last 90 days | |
| Aclarion has high historical volatility and very poor performance | |
| Aclarion has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 45.72 K. Net Loss for the year was (6.99 M) with loss before overhead, payroll, taxes, and interest of (34.06 K). | |
| Aclarion currently holds about 3.79 M in cash with (5.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Aclarion has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Aclarion Begins Patient Enrollment in Clarity Trial for Nociscan ACON Stock News |
- Analyzing Aclarion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aclarion's stock is overvalued or undervalued compared to its peers.
- Examining Aclarion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aclarion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aclarion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aclarion's stock. These opinions can provide insight into Aclarion's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.50) | Revenue Per Share 0.094 | Quarterly Revenue Growth 0.878 | Return On Assets (0.35) | Return On Equity |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.